The effects of [K+] , on taurine release from glial cells were studied with primary cultures of cerebellar astrocytes and with LRM55 cells, a continuous glial cell line. The characteristics of K+-stimulated taurine release were virtually identical in the 2 cell types. Both cerebellar astrocytes and LRM55 cells released taurine when stimulated with high-K+ medium prepared by isosmotically substituting KCI for NaCI, but neither cell type released taurine when stimulated with hyperosmotic high-K+ medium prepared by adding solid KCI to control medium. The membrane potential of LRM55 cells was measured by intracellular recording and was insensitive to changes in [K+] , below 20 mM. LRM55 cells released taurine when stimulated with nondepolarizing concentrations of K+ (13-22 mM) if the isosmotically prepared high-K+ medium was used, but the cells did not release taurine when treated with a depolarizing concentration of K+ (50 mM) if hyperosmotic high-K+ medium was used. The time course of K+-stimulated taurine release was quite slow, having a time to peak of lo-15 min. Small changes (2.5-10%) in the osmolarity of the medium strongly affected taurine release by cerebellar astrocytes and LRM55 cells. K+-stimulated taurine release from both cell types was inhibited when the osmolarity was increased with sucrose or NaCl and was enhanced when the osmolarity was reduced. Similarly, baseline taurine release was suppressed by small elevations in osmolarity and increased by reduced osmolarity. The slow time course and the high sensitivity of K+-stimulated release to initial osmotic gradients suggest that K+-stimulated taurine release from astrocytes results from the uptake of KCI and cellular swelling that occurs in isosmotically prepared high-K+ media.
High concentrations of extracellular K+ are widely used to elicit the release of neurotransmitters and other compounds from many types of nervous tissue preparations, and it is commonly assumed that release results from K+-induced depolarization. However, high [K+] , can have numerous other effects on tissue that may affect the release of small molecules by cells. In intact brain, elevated [K+] , is associated with changes in the distribution of ions between the intra-and extracellular spaces and changes in cell volume (Dietzel et al., 1980; Walz, 1987) . 1n vitro elevated [K+] , also stimulates energy metabolism, the hydrolysis of glycogen, and leads to changes in cyclic nucleotide levels, protein phosphorylation, and protein synthesis (Bull and Lutkenhoff, 1973; Shimizu et al., 1973; Forn and Greengard, 1978; Lipton and Heimbach, 1978; Hof et al., 1988) . Thus, variations in extracellular [K+] lead to numerous, complex, probably interrelated changes in fundamental cellular activities that may include release processes.
Recent studies have shown that cultured astrocytes and LRM55 cells release taurine when stimulated with elevated [K+], or neurotransmitters (Shain and Martin 1984; Madelian et al., 1985; Shain et al., 1986; Martin et al., 1987; Philibert et al., 1988) . The role of the membrane potential in glial release has not been investigated, although studies of neurotransmitter-stimulated taurine release suggest that depolarization is not involved. Neurotransmitters such as P-adrenergic agonists stimulate taurine release by a CAMP-mediated mechanism but do not appear to depolarize the cells (Madelian et al., 1985) . Furthermore, glial taurine release is Ca*+ independent Shain et al., 1989) as described by Frangakis and Kimelberg (1984) and grown in Eagle's medium supplemented with 10% fetal bovine serum for 5-7 weeks. LRM55 glial cells are a single cell clone obtained from a rat spinal tumor and possess a number of glial cell properties such as carbonic anhydrase and Cl transport Martin, 1982, 1984 (Vogel et al., 1972) supplemented with 5% fetal bovine serum. To prepare for release experiments, astrocytes and LRM55 cells were subcultured onto plastic strips (Cell Support film, Bellco Glass) and allowed to grow to confluence. Incubation media. Release experiments were conducted with a modified HEPES-buffered Hanks' saline with ascorbate (HHA) that contained (in mM): 128.7 NaCl, 4.09 KCl, 1.125 CaCl,, 0.49 M&l,, 0.21 MgSO,, 0.93 Na,HPO,, 0.45 KH,PO,, 11 glucose, 0.5 sodium ascorbate, and 10 HEPES and was adjusted to pH 7.3 with NaOH. Ascorbate was included to prevent the oxidation of isoproterenol when it was used. Modified media containing elevated [K'] were prepared by substituting KC1 for an equimolar amount of NaCl (termed isosmotic replacement) or by dissolving solid KC1 in HHA (termed hyperosmotic addition). Low-osmolarity media were prepared by adding deionized water to HHA, if the change was less than 10%; otherwise, the media were prepared by omitting an appropriate amount of NaCl. The osmolarity of the media were checked routinely with a Wescor vapor-pressure osmometer. The calculated osmolarity was 300 mOsm, and the measured osmolarity was 271.6 +-6 mOsm (mean k SD, n = 28).
Release experiments. The release of labeled amino acids was measured as previously described (Shain and Martin, 1984; Shain et al., 1986) . Briefly, the cells were incubated for about 1 hr with labeled amino acid (generally at a concentration of 10 &X/ml in HHA, ca. 300 nM) to load the cells with label. The cell support film with adherent cells was then transferred to the superfusion chamber and superfused with HHA at 0.5 ml/min. Drugs or modified medium were applied to the cells at appropriate times by a system of valves controlled by a computer. In some experiments, the superfusate was collected at 1 min intervals with a fraction collector, and the radioactivity in each sample was determined by liquid scintillation counting. In other experiments, the radioactivity in the superfusate was measured for 1 min intervals with an in-line, flow-through scintillation counter (Radiomatic Instruments).
Determination of amino acids. In some experiments, the concentrations of amino acids in the superfusate were measured by automated HPLC. Because of the low concentrations of the amino acids, a modification of our previous methods (Waniewski and Martin, 1986; Spink et al., 1988) was developed (R. A. Waniewski, personal communication). Briefly, automated precolumn derivatization was accomplished by programmed injection of 50 ~1 of derivatizing reagent followed by 200 ~1 of superfusate and a second 50 ~1 injection of derivatizing reagent. The reagents were allowed to react for 0.7 min in a precolumn reaction chamber after which the gradient elution program was begun. Electrophysiology. For these experiments, LRM55 cells were grown at a low density to minimize the formation of a glial syncytium, and recordings were made only from single, well-isolated cells. Under normal culture conditions, LRM55 cells are very similar in appearance to astrocytes in primary culture; they have a thin, flat morphology, and will change shape to form rounded process-bearing cells when treated with dibutyryl AMP or fl-adrenergic agonists . Our recordings were made with cultures having the flat morphology (i.e., cells were not treated to form process-bearing cells), and release experiments were done with cells in the same state.
Cells were bathed in HEPES-buffered Hanks' saline during recording and maintained at 34-37°C by a heating block built into the microscope stage. Cells were visualized with interference optics to provide better depth perception. Intracellular electrophysiological measurements were made with glass microelectrodes filled with 3 M potassium acetate. Recordings of membrane potential were accepted as valid only if the potential dropped immediately to a stable value upon penetration and a membrane resistance of about 50 MQ and reasonable time constant (120 msec) was observed. Because it was difficult to hold any cell longer than 5 min, a recording was considered stable if it did not fluctuate for at least 0.5 min. In most cases, recordings were stable for longer than this. In addition, the recording was not accepted as valid if there was any evidence of cell swelling or the formation of vacuoles.
Results
The membrane potential of LRM55 cells was relatively low in normal HEPES-buffered Hanks' medium (average ? SD = -43 f 3 mV, y1 = 20 cells) and was virtually insensitive to changes of [K+] , at concentrations below 20 mM (Fig. 1) (Fig. 2, second application) . Exposure to high-K+ medium prepared by hypertonic addition of KC1 did not stimulate taurine release, even though [K+], was high enough to depolarize the cells (Fig. 2, first application) . A peak of taurine release was observed when the hyperosmotic high-K+ medium was removed (Fig. 2) ; this effect is attributable to the change in osmotic pressure following the change of medium (see below). K+-stimulated taurine release was stable and reproducible; the response did not diminish during repeated applications of 50 mM isosmotitally elevated [K+] , during a 3-hr perfusion experiment (data not shown). The stimulation of taurine release in isosmotically prepared high-K+ medium was not attributable to the decrease of [Na'],, since taurine release was not stimulated by similar media in which [Na+] , was reduced by about 35 mM by isosmotically replacing Na+ with choline or N-methyl-o-glucamine (results not shown). Isosmotic substitution of 35 mM N-methylo-glucamine for Na+ did lead to a slight shift in baseline release, but the effect was small compared with the release stimulated by 0.1 FM isoproterenol (IPR). Taurine was the major amino acid released by LRM55 cells during stimulation with elevated [K+],, as shown by analysis of the superfusate by HPLC (Fig. 3) . High [K+] , also stimulated the release of aspartate and glutamate but to a much smaller degree than taurine; at the peak of release the concentrations of taurine, aspartate, and glutamate were 9.5-, 1.5-and 1.8-fold above their concentrations during baseline release. Although high K+ did not appear to stimulate the release of other amino acids, the concentration of some was below the detection limit of the HPLC method. Thus, we determined if high [K+] ,would stimulate the release of V-lysine, a representative, non-neureactive amino acid present at a low concentration. Little or no 14C-lysine release was observed with either high [K'], or IPR (data not shown).
As reported for taurine release from other systems (Kaczmarek and Davison, 1972; Oja et al., 1976; Wheler et al., 1979; Smith and Pycock, 1982; Korpi and Oja, 1983; Bernardi et al., 1984; Girault et al., 1986; Hanretta and Lombardini, 1986; Kontro and Oja, 1987) , taurine release from cultured glial cells depended strongly on [K+], (Fig. 4) . Most importantly, moreover, taurine release was strongly stimulated by low concentrations of external K+ (13-22 mM) that have little effect on the membrane potential of LRM55 cells (cf. Fig. 1) .
The onset of K+-stimulated taurine release was relatively slow, having a time to peak > 10 min (Figs. 2, 4) , and the time to peak appeared to increase as the concentration of K+ increased (Fig. 4) . (Times to peak were measured starting 3 min after the application of K+, since the flow characteristics of the superfusion system result in a 3 min delay between the time a compound is applied and the time it appears in the samples taken for radiochemical measurements.) The times are much longer than the time to peak for IPR-stimulated release, ca. 5 min (Madelian et al., 1985; Shain et al., 1986 Shain et al., , 1988 Martin et al., 1987) . As reported previously, IPR-stimulated taurine release rises rapidly to a peak and then declines equally rapidly to an elevated steady state which is maintained as long as the drug is applied (Madelian et al., 1985; Shain et al., 1986 Shain et al., , 1988 Martin et al., 1987) . With prolonged application of elevated [K'], (35 min), K+-stimulated release also rose to a peak and then de- clined, but the decline was slower and much smaller than observed with IPR (data not shown). Although peak rates of release were similar with IPR and K+, total taurine release was greater with K+, particularly at higher concentrations, because K+-stimulated release was sustained at a high rate for a longer period.
The observation that high [K+] , stimulates taurine release from astroglial cells when elevated isosmotically but not when added hyperosmotically (Fig. 2) suggested that the transmembrane osmotic pressure difference is an important factor in taurine release. Subsequent experiments indicated that taurine release is extremely sensitive to the osmolarity of the medium. K+-stimulated taurine release by both LRM55 cells and primary cultures of astrocytes was suppressed by elevating the osmolarity of the medium with sucrose (Fig. 5) . Raising the osmotic pressure of the medium with NaCl had the same effect (data not shown). Conversely, reducing the osmotic pressure of the medium greatly enhanced K+-stimulated taurine release (Fig. 6) . Only small changes in osmolarity were necessary to affect the response to KCl; a 5% increase in osmolarity (15 mM added sucrose) suppressed the response to 50 mM [K+] , almost completely (Fig. 5B) , and a 5% decrease in osmolarity substantially increased the response to [K+] , (Fig. 6) .
K+-stimulated taurine release was also Cll dependent. As shown in Figure 7 , K+-stimulated release was greatly diminished when [Cl-] , was reduced to 12.33 mM (second application) from the concentration (136 mM) present during the first and third applications of high-K+ medium and in the baseline perfusate The osmotic pressure of the medium was reduced by 5% for 10 min before, during, and 10 min after the second application of high-K+ medium. Media are described in Materials and Methods.
(HEPES-buffered Hanks').
[K+], was isosmotically elevated from 4.54 to 50 mM during each application. We reduced [Cl-], to 12.33 mM to keep the [K+] .
[Cll] product equal to that ofcontrol medium and thereby minimize the ion shifts and accompanying swelling resulting from Gibbs-Donnan equilibrium forces. The baseline rate of taurine release was also affected by small changes in the osmolarity of the medium (Fig. 8) . Baseline release was increased by a small reduction in osmolarity (7.5 mOsM) and was suppressed significantly by raising the osmolarity by as little as 9 mOsM, whether osmotic pressure was increased with sucrose or NaCl. The calculated osmolarity of control HHA is 300 mOsM. Thus, changing the osmolarity by only about 2.5% significantly affected baseline taurine release. Similar results were observed with cerebellar astrocytes; the baseline rate of release was 124 f 2% of control when osmolarity was reduced by 5% (mean f SEM, n = 6) and was 68 ? 3% of control when the osmolarity was increased 20 mOsM by adding sucrose. Similar changes in baseline were observed when the osmolarity was reduced by manipulating sucrose at a constant reduced ionic strength. Thus, the baseline rate of release increased to 160 f 10% o(fcontro1 when the medium was changed from one containing 7.5 mM sucrose and 97.5% of the normal levels of salts to a medium containing the same levels of salts but no sucrose.
The time course of the shift in the baseline differed somewhat with the change in osmolarity (Fig. 9) . When the osmolarity was raised, baseline release immediately decreased and remained low until control HHA was reapplied to the cells. At that time, there was often a peak of release followed by a return to the baseline originally observed with HHA. When the osmolarity of the medium was reduced by a relatively small amount (e.g., 5%), baseline release rapidly increased to a new steady-state rate. With a larger reduction in osmolarity (ca. lo%), release increased rapidly to a peak and then declined to a new, elevated , were isosmotically adjusted to 50 and 12.33 mM by replacing KC1 and partially replacing NaCl with appropriate amounts of potassium gluconate and sodium gluconate. All other components of the medium were unchanged.
baseline that remained elevated until the medium was changed (30 min in the longest experiments).
Discussion
The high sensitivity of both baseline and K+-stimulated taurine release to the osmolarity of the medium suggests that physical tension on the cell membrane is an important controlling element in taurine release-that is, treatments that increase membrane tension will increase taurine release, and treatments that decrease membrane tension will decrease release. Exposure to media with low osmolarity causes astroglial swelling (Kimelberg and Goderie, 1988) , undoubtedly an increase in membrane tension, and taurine release (our data and Pasantes- Morales and Schousboe, 1988) . Similarly, cultured astrocytes swell in isosmotic high-K+ medium (Walz, 1987; Walz and Mukerji, 1988) and release taurine (our data and Philibert et al., 1988) . Conversely, raising the osmotic pressure of the medium, which inhibits taurine release, would be expected to cause cells to shrink and relieve the tension on the membrane. The Cl-dependence and time course of K+-stimulated release is also consistent with the swelling and membrane-tension hypothesis. K+-induced swelling appears to result from the accumulation of high levels of KC1 by the cells (Walz, 1987; Walz and Mukerji, 1988) , and we observed little or no K+-stimulated taurine release in a lowCl-medium designed to minimize swelling due to Gibbs-Donnan forces. We also have found that KC1 uptake by LRM55 cells is relatively slow, requiring more than 10 min to come to steady state at 37°C (Wolpaw and Martin, 1984) , a time that correlates well with the 1 O-l 5 min time to peak of K+-stimulated taurine release. This mechanism is also consistent with the apparent increase in time to peak as [K'], is increased, since the time required to complete the ion movements would be greater at higher [K'],, where net ion movements are greater (Wolpaw and Martin, 1984) . In recent years, Sachs and coworkers have described transmembrane ion channels that respond to changes in membrane tension in a variety of cell types, including astrocytes (Guharay (0) or NaCl (A) and was decreased (0) as described in Materials and Methods. Similar effects were observed with cerebellar astrocytes (see text). The shift in baseline was determined by averaging the fractional release rate over a 1 O-l 2 min period before application of the altered medium and after the new steady-state rate of release was attained.
and Sachs, 1984 Sachs, , 1985 Ding et al., 1988) . These channels, termed stretch channels, open when membrane tension is increased and close when the membrane is relaxed. Although all of the stretch channels described to date are cation selective and none appear to have appropriate properties to account for taurine release, they are a well-documented example of a specific, tension-dependent permeability mechanism.
The role of membrane potential in release processes is complex. In neurons and other cells that have vesicular release mechanisms, depolarization opens voltage-gated Ca*+ channels leading to an influx of Ca*+ that activates the release mechanism. Not surprisingly, this mechanism does not appear to apply to glial taurine release. LRM55 cells readily release taurine when [K+] , is isosmotically increased to 10 or 20 mM but are not Glial taurine release differs in another fundamental way from transmitter release at the synapse, as glial release is not Ca*+ dependent Shain et al., 1989) . We have found that glial taurine release is not blocked by using Ca2+-free medium containing 10 PM EGTA, by replacing extracellular Ca2+ with CO*+, Cd2+, or Mn2+, or by the organic Caz+-channel blockers verapamil, diltiazem, or nifedipine . We and others (Philibert et al., 1988; Martin et al., 1989) have found that taurine release is inhibited by 10 mM MgCl, in Ca2+-free medium, but this is attributable to elevated osmotic pressure and is not a sign of Ca*+ dependency, since added NaCl and sucrose inhibit similarly.
The characteristics of K+-stimulated release from cultured astrocyte cells is similar in many ways to K+-stimulated taurine release in intact tissue preparations, suggesting that release from astrocytes is at least partially responsible for K+-evoked taurine release from brain tissue. As shown here, K+-evoked taurine release is relatively slow in astroglial cells, and K+-stimulated taurine release from brain slices, retina, or in vivo lags behind the release of neurotransmitter amino acids such as GABA, glycine, or glutamate (Smith and Pycock, 1982; Girault et al. 1986; Kontro and Oja, 1987) . As noted above, glial taurine release is CaZ+-independent. In most other systems, K+-stimulated taurine release appears to be independent of external Ca2+ or to have a large component of Ca*+ -independent release. K+-stimulated taurine release from dorsal medulla (Bernardi et al., 1984) and striatum (Girault et al., 1986) in vivo is CaZ+ independent, and release from cerebellum in vivo is partially Ca*+ dependent (Bernardi et al., 1984) . With brain slices, K+-stimulated taurine release was reduced or delayed but not eliminated in studies of Ca*+ dependency (Kaczmarek and Davison, 1972; Oja et al., 1976; Wheler et al., 1979; Korpi and Oja, 1983) . These similarities suggest that KC1 accumulation and cellular swelling contribute to taurine release in vivo and in brain slices. It has been known for many years that brain and brain slices swell in isosmotic high- [K+] , medium (Varon and McIlwain, 196 1; Bourke and Tower, 1966; Bourke et al., 1970) .
K+-stimulated taurine release may be a normal physiological response of astrocytes in viva. [K+] , rises significantly during normal neuronal activity and can reach values of lo-12 mM during periods of extreme activity such as seizures (Moody et al., 1974; Sypert and Ward, 1974; Heinemann and Lux, 1977) . The increase in [K+] , is accompanied by a decrease in extracellular space, indicating that the cells are swelling (Dietzel et al. 1980 ). This swelling has been attributed to osmotic imbalantes across the astrocytic membrane due to the movement of K+ and anions resulting from spatial buffering and changes in the HCO,-/Cl-balance (Dietzel et al., 1980; Kimelberg and Ransom, 1986) . In our view, elevated extracellular K+ and the associated astrocytic swelling will lead to taurine release, as almost identical conditions cause taurine release from cultured astrocytes. Taurine is also released from brain tissue in vivo under other conditions that are accompanied by glial swelling, including seizures, ischemia, hypoglycemia, and perfusion with hypotonic medium (Benveniste et al., 1984; Tossman et al., 1985; Vezzani et al., 1985; Butcher and Hamberger, 1987; Solis et al., 1988; Wade et al., 1988) . It has been suggested that this taurine release might have an osmoregulatory function (Pasantes- Morales and Schousboe, 1988; Solis et al., 1988; Wade et al., 1988) . Although osmotic sensitivity might suggest osmoregulation, it is not clear that taurine is present or is released in sufficient amounts in brain to substantially change the osmotic balance across the cell membrane (Martin et al., 1990 ). An alternative mechanism of osmoregulation might be envisaged (e.g., a hormone-like action of taurine), but there is no evidence for such a mechanism. Taurine does have inhibitory effects on certain neurons (Krnjevic and Puil, 1976; Okamoto et al, 1983) , and taurine release might have a dampening effect on neuronal activity under conditions where swelling occurs, thereby reducing the further release of K+ and preventing some additional swelling.
